tellbio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Disallow: /.well-known/ Allow:
Meta Tags
Title TellBio - Freeing Patients from The Tyranny of
Description TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform,
Keywords N/A
Server Information
WebSite tellbio favicontellbio.com
Host IP 209.99.16.228
Location United States
Related Websites
Site Rank
More to Explore
tellbio.com Valuation
US$3,010,911
Last updated: 2023-05-07 23:46:49

tellbio.com has Semrush global rank of 3,515,316. tellbio.com has an estimated worth of US$ 3,010,911, based on its estimated Ads revenue. tellbio.com receives approximately 347,413 unique visitors each day. Its web server is located in United States, with IP address 209.99.16.228. According to SiteAdvisor, tellbio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,010,911
Daily Ads Revenue US$2,780
Monthly Ads Revenue US$83,380
Yearly Ads Revenue US$1,000,549
Daily Unique Visitors 23,161
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
tellbio.com. A 7199 IP: 209.99.16.228
tellbio.com. NS 7200 NS Record: ns47.worldnic.com.
tellbio.com. NS 7200 NS Record: ns48.worldnic.com.
tellbio.com. MX 3600 MX Record: 0 tellbio-com.mail.protection.outlook.com.
tellbio.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
tellbio.com. TXT 3600 TXT Record: MS=ms58433195
HtmlToTextCheckTime:2023-05-07 23:46:49
Home Platforms Platforms Our Story Our Story Team News & Presentations References Main Menu Welcome to TellBio Freeing patients from the tyranny of cancer™ About Us TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, TellDx and TellRx, respectively. TellBio’s vision is to free patients and their families from the tyranny of cancer via both its TellDx and TellRx platforms. The foundation of the Company’s approach – detection of and targeting CTCs – is exclusively licensed from Massachusetts General Hospital and is based on decades of academic and clinical research. References A diagnostics solution that detects circulating tumor cells (CTCs). A therapeutics platform that generates novel anti-cancer drugs targeting CTCs. Platforms Integration of TellDx and TellRx platforms offers TellBio a unique
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 28 Oct 2021 23:27:20 GMT
Server: Apache
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://tellbio.com/
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-type: text/html; charset=UTF-8
date: Thu, 28 Oct 2021 23:27:21 GMT
server: Apache
tellbio.com Whois Information
Domain Name: TELLBIO.COM
Registry Domain ID: 2418251432_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-07-06T14:30:21Z
Creation Date: 2019-07-30T00:40:58Z
Registry Expiry Date: 2025-07-30T00:40:58Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: ok https://icann.org/epp#ok
Name Server: NS47.WORLDNIC.COM
Name Server: NS48.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T14:34:20Z <<<